Profound Medical (PROF) Depreciation & Amortization (CF) (2024 - 2026)
Profound Medical's (PROF) quarterly Depreciation & Amortization (CF) came in at $93000.0 in Q1 2026, down 19.83% year-on-year from $116000.0 in Q1 2025, and up 50.0% quarter-over-quarter from $62000.0 in Q4 2025.
Profound Medical (PROF) Depreciation & Amortization (CF) (2024 - 2026) Analysis & Trends
Profound Medical's Depreciation & Amortization (CF) history runs 3 years deep, the most recent figure standing at $93000.0 for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 19.83% year-over-year to $93000.0 in Q1 2026; TTM through Mar 2026 was $350000.0, a 43.91% decrease from a year earlier, with the FY2025 full-year figure at $373000.0, down 47.24% from the prior year.
- Depreciation & Amortization (CF) climbed to $93000.0 in Q1 2026 per PROF's latest filing, from $62000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $199000.0 in Q1 2024 and bottomed at $62000.0 in Q4 2025.
- The 3-year median for Depreciation & Amortization (CF) is $116000.0 (2025), against an average of $130333.3.
- Across the five-year window, Depreciation & Amortization (CF) slumped 61.25% in 2025 and slipped 19.83% in 2026, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $160000.0 in 2024, then slumped by 61.25% to $62000.0 in 2025, then surged by 50.0% to $93000.0 in 2026.
- Per Business Quant, the three latest PROF Depreciation & Amortization (CF) figures stand at $93000.0 (Q1 2026), $62000.0 (Q4 2025), and $93000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn | 40.90 Mn |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn | 78.00 Mn |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 67.10 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 310.25 Mn |
| 10 | Profound Medical | 280.60 Mn | 230.30 Mn | 3.83 Mn | 93,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93,000.00 |
| Mar 31, 2026 | 93,000.00 |
| Dec 31, 2025 | 62,000.00 |
| Dec 31, 2025 | 62,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 102,000.00 |
| Jun 30, 2025 | 102,000.00 |
| Mar 31, 2025 | 116,000.00 |
| Mar 31, 2025 | 116,000.00 |
| Dec 31, 2024 | 160,000.00 |
| Dec 31, 2024 | 160,000.00 |
| Sep 30, 2024 | 164,000.00 |
| Sep 30, 2024 | 164,000.00 |
| Jun 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 184,000.00 |
| Mar 31, 2024 | 199,000.00 |
| Mar 31, 2024 | 199,000.00 |